Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.81 |
| ▸ | TSHR | P16473 | 4/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.70 |
| ▸ | KDM4A | O75164 | 1/20 | 0.56 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8927603 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1923016 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1005991 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| 2-Hydroxybenzoic Acid Hexyl Ester SCHEMBL113059 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL4731100 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL8927962 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL7459965 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL411474 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL2801630 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL2798676 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 667 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688909-A1 | POLYESTER ELASTOMERS FROM DI-CARBOXYLIC ACID OR TRI-CARBOXYLIC ACID, MONO-CARBOXYLIC ACID, AND POLYOL FOR COSMETIC AND PERSONAL CARE APPLICATIONS | Momentive Performance Materials Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4688908-A2 | CROSSLINKED POLYESTER ELASTOMERS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF | Momentive Performance Materials Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | L'OREAL (FR) | 2026-02-05 | — | — | US | claimed |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | L'OREAL (FR) | 2026-01-01 | — | — | US | claimed |
| US-20250257281-A1 | LUBRICANT COMPOSITIONS AND METHODS OF DRY LUBRICATING SURFACE USING THE SAME | DIVERSEY, INC. (US) | 2025-08-14 | — | — | US | claimed |
| US-20250205125-A1 | Skin Protection Compositions | DUETTE INC. | 2025-06-26 | — | — | US | claimed |
| CN-120154538-A | Ultra-broad-spectrum multi-effect composite sun-screening carrier containing DHHB, IMC and DHBT, and preparation and application thereof | 武汉百思凯瑞生物科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| EP-4547194-A1 | COSMETIC FORMULATIONS COMPRISING STABLE HOMOGENEOUS AQUEOUS SUSPENSION OF BIOPOLYMERS | 11584022 Canada Inc. (CA) | 2025-05-07 | — | — | EP | claimed |
| CN-119894483-A | Cosmetic preparation comprising a stable homogeneous aqueous suspension of a biopolymer | 11584022加拿大有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2025072721-A1 | COMPOSITIONS | UVAGELESS LLC (US) | 2025-04-03 | — | — | WO | claimed |
| EP-0886517-A1 | METHOD FOR REDUCING SKIN OILS AND GREASE | UNILEVER PLC (GB) | 1998-12-30 | — | — | EP | claimed |
| EP-0881896-A1 | SKIN TREATMENT WITH SALICYLIC ACID ESTERS AND RETINOIDS | UNILEVER PLC (GB) | 1998-12-09 | — | — | EP | claimed |
| US-5773015-A | DEGREASING SKINS | ELIZABETH ARDEN CO., DIVISION OF CONOPCO, INC. (US) | 1998-06-30 | — | — | US | claimed |
| WO-1998023257-A1 | METHOD FOR REDUCING SKIN OILS AND GREASE | UNILEVER PLC (GB) | 1998-06-04 | — | — | WO | claimed |
| US-5744148-A | CONTAINING A HYDROXY ACID | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1998-04-28 | — | — | US | claimed |
| US-5741497-A | TRIDECYL SALICYLATE | ELIZABETH ARDEN COMPANY (US) | 1998-04-21 | — | — | US | claimed |
| EP-0832643-A2 | Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions | UNILEVER PLC (GB) | 1998-04-01 | — | — | EP | claimed |
| US-5728732-A | TRIDECYL SALICYLATE, RETINYL LINOLEATE SYNERGISTIC; FOR CHRONO AGING OR ENVIRONMENTAL ABUSE | ELIZABETH ARDEN COMPANY, DIVISION OF CONOPCO, INC. (US) | 1998-03-17 | — | — | US | claimed |
| WO-1997030691-A1 | SKIN TREATMENT WITH SALICYLIC ACID ESTERS AND RETINOIDS | UNILEVER PLC (GB) | 1997-08-28 | — | — | WO | claimed |
| WO-1997030690-A1 | SKIN TREATMENT WITH SALICYLIC ACID ESTERS | UNILEVER PLC (GB) | 1997-08-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | TAS2R40, BRDT, APOB | ALDH1A1 1428/4885TSHR 1183/4885LMNA 1502/4885 |
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | KRT18, DSG1, PRKDC | ALDH1A1 983/4885TSHR 1321/4885LMNA 586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.